RocketVax raises fresh capital The Basel-based biotech startup RocketVax has successfully closed another financing round. This additional funding will…martin02.07.2023
Clinerion is now part of Citeline Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio…martin02.02.2023
Cell and gene therapies gain momentum in Basel Companies specializing in the research and development of innovative cell and gene therapies continue to…martin01.23.2023
Combatting the rise of antimicrobial resistance Antimicrobial resistance is a growing global threat that, without intervention, could lead to as many…martin01.11.2023
AMR Action Fund invests in new antibiotics developed by BioVersys The AMR Action Fund has made its first European investment in BioVersys, which is headquartered…martin01.06.2023
Investors give Resistell 8.5 million Swiss francs Resistell AG has secured 8.5 million Swiss francs in the first part of its series…martin12.23.2022
Europe’s booming biotech powerhouse is called Basel The first places to spring to mind when most people think of “life sciences hubs”…martin12.10.2022
South Korean pharma firms show interest in the Basel Area Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited…martin11.28.2022
Databaum establishes headquarters in Basel Databaum is establishing its headquarters in Basel and plans to grow from its location there.…martin11.14.2022
Clinerion launches patient information platform Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals…martin11.10.2022